SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
自信的yu
Lv1
30 积分
2023-10-30 加入
最近求助
最近应助
互助留言
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
13天前
已完结
Oral Anticoagulant Agents in Patients With Atrial Fibrillation and CKD: A Systematic Review and Pairwise Network Meta-analysis
13天前
已完结
Comparison of clinical performance of four gastrointestinal bleeding risk scores in Chinese patients with atrial fibrillation receiving oral anticoagulants
15天前
已完结
A Step Forward for Precision Equity in Kidney Disease
15天前
已完结
The Coagulopathy of Chronic Liver Disease
1个月前
已完结
Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale
1个月前
已完结
Apixaban versus warfarin in patients with atrial fibrillation
1个月前
已完结
Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation
1个月前
已完结
Revised A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey
1个月前
已完结
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)
1个月前
已完结
没有进行任何应助
不是需要的原文,这是评论
1个月前
文章缺页,看不了全文
1个月前
弄错了【积分已退回】
3个月前
感谢
3个月前
感谢
6个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论